|
Volumn 92, Issue 13, 1995, Pages 5855-5859
|
A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo
a a a a a a b c a |
Author keywords
antigene; cell cycle regulatory genes; hemagglutinating virus of Japan; restenosis
|
Indexed keywords
CYCLINE;
DOUBLE STRANDED DNA;
OLIGODEOXYNUCLEOTIDE;
TRANSCRIPTION FACTOR;
ANIMAL CELL;
ANIMAL MODEL;
ARTERY INTIMA PROLIFERATION;
ARTICLE;
CELL PROLIFERATION;
COMMON CAROTID ARTERY;
CONTROLLED STUDY;
DNA SYNTHESIS;
GENE THERAPY;
GENETIC TRANSCRIPTION;
GENETIC TRANSFECTION;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
REGULATOR GENE;
TRANSACTIVATION;
VASCULAR SMOOTH MUSCLE;
ANIMAL;
AORTA;
BASE SEQUENCE;
BINDING SITES;
CELL DIVISION;
CELL NUCLEUS;
CELLS, CULTURED;
COMPARATIVE STUDY;
DNA PRIMERS;
DRUG CARRIERS;
GENE THERAPY;
GENES, MYC;
LIPOSOMES;
MOLECULAR SEQUENCE DATA;
MUSCLE, SMOOTH, VASCULAR;
OLIGODEOXYRIBONUCLEOTIDES;
POLYMERASE CHAIN REACTION;
PROLIFERATING CELL NUCLEAR ANTIGEN;
PROMOTER REGIONS (GENETICS);
PROTEIN P34CDC2;
RATS;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
TRANS-ACTIVATION (GENETICS);
TRANSCRIPTION FACTORS;
TRANSFECTION;
ANIMALIA;
|
EID: 0029031549
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.92.13.5855 Document Type: Article |
Times cited : (487)
|
References (28)
|